Dyne Therapeutics Inc (NAS:DYN)
$ 26 0.05 (0.19%) Market Cap: 2.27 Bil Enterprise Value: 1.85 Bil PE Ratio: 0 PB Ratio: 4.69 GF Score: 37/100

Dyne Therapeutics Inc Industry Updates Friday Transcript

Oct 06, 2020 / NTS GMT
Release Date Price: $18.84 (-0.42%)
Allison Formal
Myotonic Dystrophic Foundation - Moderator

I hope you've been enjoying the first day of MDF's first virtual conference. I'm Allison Formal, the Senior Science Advisor at MDF.

Welcome to this special time in our annual conference where our industry partners come together to share updates about their myotonic dystrophy programs and their cutting-edge work and the development of different therapeutics. This is a chance for us to hear directly from our partners about their approach, their process, and their progress.

Today, we will hear from Avidity Biosciences, Ionis Pharmaceuticals, Dyne Therapeutics, and NeuBase. Unfortunately, we're short on time. So, we will not have the opportunity to ask speakers questions during the session.

However, many of our industry partners have exhibit booth, which will be open for live chat until 6:00 PM this evening. So, if you have follow-up questions after this session, go to the exhibitors' tab on the menu bar on the conference website, select conference exhibitors, and click on the company that you're interested in connecting with.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot